Trial intelligence / Profile preview

Intraoperative near-infrared fluorescence imaging of endometriosis with OTL38: a pilot study

2018-003693-27Phase 2Active

Sponsor
Leiden University Medical Center
Start
Jan 2019
Modality
Light/Condition-Responsive Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 2, open-label, single-arm trial of pafolacianine in endometriosis, sponsored by Leiden University Medical Center. Started Jan 2019; status: active.

02

Drugs

pafolacianine
03

Conditions

endometriosis

Beyond the preview

Go deeper on 2018-003693-27.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2018-003693-27.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call